THÔNG TIN TÀI LIỆU
Thông tin cơ bản
Định dạng | |
---|---|
Số trang | 43 |
Dung lượng | 365,11 KB |
Nội dung
Ngày đăng: 05/07/2020, 16:33
Nguồn tham khảo
Tài liệu tham khảo | Loại | Chi tiết |
---|---|---|
10. Gerber, Y., et al., A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med, 2015. 175(6): p. 996-1004 | Khác | |
11. Owan, T.E., et al., Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med, 2006. 355(3): p. 251-9 | Khác | |
12. Meta-analysis Global Group in Chronic Heart, F., The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J, 2012. 33(14): p. 1750-7 | Khác | |
13. Kalogeropoulos A., G.V., Kritchevsky S.B., et al, Epidemiology of Incident Heart Failure in a Contemporary Elderly Population: The Health, Aging, and Body Composition Study. Arch Intern Med, 2009.169(7): p. 708–715 | Khác | |
14. Ponikowski, P., et al., 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail, 2016. 18(8): p. 891-975 | Khác | |
15. Killip, T., 3rd and J.T. Kimball, Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol, 1967. 20(4): p. 457-64 | Khác | |
17. Wang, T.J., et al., Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation, 2003. 108(8): p.977-82 | Khác | |
18. Group, S.R., et al., A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med, 2015. 373(22): p. 2103-16 | Khác | |
19. Sciarretta, S., et al., Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk. Arch Intern Med, 2011. 171(5): p. 384-94 | Khác | |
20. Zinman, B., et al., Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med, 2015. 373(22): p. 2117- 28 | Khác | |
21. Dargie, H.J., Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet, 2001. 357(9266): p. 1385-90 | Khác | |
22. Montalescot, G., et al., Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study. Eur Heart J, 2014. 35(34):p. 2295-302 | Khác | |
23. Garg, R. and S. Yusuf, Overview of randomized trials of angiotensin- converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.JAMA, 1995. 273(18): p. 1450-6 | Khác | |
25. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet, 1999. 353(9169): p. 2001-7 | Khác | |
26. Kotecha, D., et al., Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.Lancet, 2014. 384(9961): p. 2235-43 | Khác | |
27. Zannad, F., et al., Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med, 2011. 364(1): p. 11-21 | Khác | |
28. McMurray, J.J., et al., Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med, 2014. 371(11): p. 993-1004 | Khác | |
29. Crespo-Leiro, M.G., et al., European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail, 2016. 18(6): p. 613-25 | Khác |
HÌNH ẢNH LIÊN QUAN
TRÍCH ĐOẠN
TÀI LIỆU CÙNG NGƯỜI DÙNG
TÀI LIỆU LIÊN QUAN